| 000 | 01860 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516221125.0 | ||
| 264 | 0 | _c20150214 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1097-0215 | ||
| 024 | 7 |
_a10.1002/ijc.29040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGobin, Bérengère | |
| 245 | 0 | 0 |
_aBYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cFeb 2015 |
||
| 300 |
_a784-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aHuin, Marc Baud' | |
| 700 | 1 | _aLamoureux, François | |
| 700 | 1 | _aOry, Benjamin | |
| 700 | 1 | _aCharrier, Céline | |
| 700 | 1 | _aLanel, Rachel | |
| 700 | 1 | _aBattaglia, Séverine | |
| 700 | 1 | _aRedini, Françoise | |
| 700 | 1 | _aLezot, Frédéric | |
| 700 | 1 | _aBlanchard, Frédéric | |
| 700 | 1 | _aHeymann, Dominique | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 136 _gno. 4 _gp. 784-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.29040 _zAvailable from publisher's website |
| 999 |
_c23949848 _d23949848 |
||